Inno Shred is marketed like its in the same league as prescription GLP-1s, so lets see how it stacks up next to clinics that actually provide prescriptions and real care: Swipe to scroll the table below Want real results
For example, SGLT2i use leads to a 33% reduction (95% CI 26, 38) in hospitalisation for heart failure (HF) and a 35% reduction (95% CI 19, 47) in the incidence of end-stage kidney disease (ESKD) [3, 4], and GLP-1 RA use leads to a 10% reduction (95% CI 2, 17) in myocardial infarction (MI) and a 17% reduction (95% CI 8, 24) reduction in stroke [2]
Nutrient Support: Using targeted supplements to fill nutritional gaps
Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis
A 2023 analysis published in the *Journal of the American Medical Association* (JAMA) examined compounded semaglutide products and found that approximately 40% contained impurities, incorrect concentrations, or failed sterility testing
Reviewed by the PeptideMind Team Updated July 16, 2026 Glow Blend (GHK-Cu, BPC-157, TB-500) Dosage Guide, Benefits & Side Effects This collagen and tissue-repair stack combines three peptides for faster wound healing, firmer skin, and musculoskeletal recovery
